Search alternatives:
largest decrease » largest decreases (Expand Search), marked decrease (Expand Search)
larger decrease » marked decrease (Expand Search)
mean decrease » a decrease (Expand Search)
we decrease » _ decrease (Expand Search), a decrease (Expand Search), nn decrease (Expand Search)
largest decrease » largest decreases (Expand Search), marked decrease (Expand Search)
larger decrease » marked decrease (Expand Search)
mean decrease » a decrease (Expand Search)
we decrease » _ decrease (Expand Search), a decrease (Expand Search), nn decrease (Expand Search)
-
6241
-
6242
Overall analysis of randomized controlled trials.
Published 2025“…Notably, atorvastatin demonstrated the most significant reduction in IL-6 and TNF-α levels, while fluvastatin and rosuvastatin displayed the greatest impact on decreasing CRP and LDL-C levels, respectively. Stratification by a longer treatment duration of more than four months revealed that atorvastatin achieved the most significant reduction in IL-6 and TNF-α. …”
-
6243
Newcastle-Ottawa scale.
Published 2025“…Notably, atorvastatin demonstrated the most significant reduction in IL-6 and TNF-α levels, while fluvastatin and rosuvastatin displayed the greatest impact on decreasing CRP and LDL-C levels, respectively. Stratification by a longer treatment duration of more than four months revealed that atorvastatin achieved the most significant reduction in IL-6 and TNF-α. …”
-
6244
Modeling of <i>In-Utero</i> and <i>Intra-Partum</i> Transmissions to Evaluate the Efficacy of Interventions for the Prevention of Perinatal HIV
Published 2015“…</p><p>Trial Registration</p><p>This analysis is based on secondary data obtained from three clinical trials. ClinicalTrials.gov. <a href="https://clinicaltrials.gov/ct2/show/NCT00386230" target="_blank">NCT00386230</a>, <a href="https://clinicaltrials.gov/ct2/show/NCT00398684" target="_blank">NCT00398684</a>, <a href="https://clinicaltrials.gov/ct2/show/NCT00409591" target="_blank">NCT00409591</a>.…”
-
6245
-
6246
-
6247
-
6248
-
6249
-
6250
-
6251
-
6252
-
6253
-
6254
-
6255
Structural details for each point mutation studied by X-ray crystallography in this study.
Published 2023Subjects: -
6256
-
6257
-
6258
-
6259
-
6260